Description Actuate Therapeutics
Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing targeted therapies for difficult-to-treat cancers. Its pipeline includes elraglusib, a glycogen synthase kinase-3 beta inhibitor being evaluated in combination with other treatments.